Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice

BACKGROUND: Olanzapine long-acting injection (LAI) for the treatment of schizophrenia was associated with a cluster of symptoms termed post-injection delirium/sedation syndrome (PDSS) in a small percentage (~2%) of patients during clinical trials. The objective of this analysis was to evaluate the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bushe, Chris J, Falk, Deborah, Anand, Ernie, Casillas, Marta, Perrin, Elena, Chhabra-Khanna, Rashna, Detke, Holland C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389990/
https://www.ncbi.nlm.nih.gov/pubmed/25886006
http://dx.doi.org/10.1186/s12888-015-0450-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389990/
https://www.ncbi.nlm.nih.gov/pubmed/25886006
http://dx.doi.org/10.1186/s12888-015-0450-9

Ejemplares similares